Tehran (IP) - The head of the Razi Vaccine and Serum Research Institute stated that the Razi Institute is preparing to start the clinical trials of phases 1 and 2 of the corona vaccine.

Iran PressIran News: In response to the reporter's questions about the certification for the start of phases 1 and 2 of the first Iranian COVID-19 vaccine clinical trial, Ali Eshaqi, the head of Razi Vaccine and Serum Research Institute, said that will begin soon.

He added: "The clinical trial of this vaccine will start soon and we hope that with the support of a hundred years of national and international knowledge and experience of Razi Institute in vaccine production, this vaccine will be produced as a safe vaccine soon in the country."

207

Read more:

Iran, Cuba to produce millions of doses of coronavirus vaccine

Pfizer-BioNTech reduced the number of vaccine to EU countries